Mark S. Levi - Concepedia

Author

Mark S. Levi

United States Food and Drug Administration

Also Known As

M Levi, M. LEVI, M. Levi, M.S. Levi, Mark Levi, Mark S Levi, Mark S. Levi, P.N. Newton

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

United States Food and Drug Administration University of Mississippi National Center for Toxicological Research

About

Mark S. Levi is an author at United States Food and Drug Administration specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	1.2K
2	Biochemistry	3	3	95
3	Engineering	1	1	59
4	Natural Sciences	1	1	39
5	Allergy	1	1	17

Mark S. Levi

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Guidelines for the diagnosis and management of disseminated intravascular coagulation Mark S. Levi, Cheng‐Hock Toh, Jecko Thachil, British Journal of Haematology ThrombosisCardiovascular DiseaseStrokeMedicineHematology	2009	1.1K
Three-way chemometric method study and UV-Vis absorbance for the study of simultaneous degradation of anthocyanins in flowers of the Hibiscus rosa-sinensys species Mark S. Levi Talanta Chemical EngineeringPlant AnalysisEngineeringBotanyHibiscus Rosa-sinensys Species	2003	59
Synthesis of isoquinuclidine analogs of chloroquine: Antimalarial and antileishmanial activity Madeeha Khan, Mark S. Levi, Babu L. Tekwani, Bioorganic & Medicinal Chemistry Medicinal ChemistryNatural Product SynthesisBiochemistryAntiparasitic AgentMedicine	2006	39
A comparison of methylphenidate-, amphetamine-, and methamphetamine-induced hyperthermia and neurotoxicity in male Sprague–Dawley rats during the waking (lights off) cycle Mark S. Levi, Becky Divine, Joseph P. Hanig, Neurotoxicology and Teratology Psychoactive DrugMedicineBehavioural PharmacologyPhysiologyNeuropharmacology	2012	32
A Visual Description of the Dissection of the Cerebral Surface Vasculature and Associated Meninges and the Choroid Plexus from Rat Brain John F. Bowyer, Monzy Thomas, Tucker A. Patterson, Journal of Visualized Experiments	2012	32
A systematic comparison of factors that could impact treatment recommendations for patients with Positional Obstructive Sleep Apnea (POSA) Daniel J. Levendowski, Arie Oksenberg, Claudio Vicini, Sleep Medicine	2018	31
Synthesis and Antimalarial Activities of Cyclen 4-Aminoquinoline Analogs Madeeha Khan, Mark S. Levi, Babu L. Tekwani, Antimicrobial Agents and Chemotherapy BiochemistryAntiparasitic AgentMedicineMalariaCyclen 4-Aminoquinoline Analogs	2009	30
Synthesis and pharmacological evaluation of glycine-modified analogues of the neuroprotective agent glycyl-l-prolyl-l-glutamic acid (GPE) Michelle Y. H. Lai, Margaret A. Brimble, David J. Callis, Bioorganic & Medicinal Chemistry Glycine-modified AnaloguesBiochemistryMedicineGlycobiologyPharmacological Agent	2004	26
Retraction: The Dietary Polyphenols trans-Resveratrol and Curcumin Selectively Bind Human CB1 Cannabinoid Receptors with Nanomolar Affinities and Function as Antagonists/Inverse Agonists Kathryn A. Seely, Mark S. Levi, Paul L. Prather Journal of Pharmacology and Experimental Therapeutics	2009	22
An improved size exclusion-HPLC method for molecular size distribution analysis of immunoglobulin G using sodium perchlorate in the eluent Hsiaoling Wang, Mark S. Levi, Alfred V. Del Grosso, Journal of Pharmaceutical and Biomedical Analysis AllergySodium PerchlorateMass SpectrometryImmunologyImmunodominance	2017	17

Page 1